English
This Έργο is not specific to Greece. For more details, please visit OpenAIRE Explore.
Link with research outputs.
Please log in first and try again.
A randomized phase III study of Velcade-Melphalan 200 conditioning regimen versus Melphalan 200 for frontline transplant eligible patients with multiple myeloma
FunderInstitut National du Cancer
Funded underPHRC
Call for proposalPHRC13
Project codeINCa-DGOS-7292
Open Access mandatePublications: NoResearch data: No
Identifiers
Description
N/A
Partners (27)
Start a new DMP in Loading
